Melhores Anemia aplástica médicos em Israel - TOP-18 médicos

As informações do médico estão sendo atualizadas no momento. O Dr. Ron atua no Sourasky Medical Center (Ichilov).

O Dr. Ram realizou centenas de transplantes de células estaminais – um tratamento fundamental para a anemia aplástica – no Sourasky Medical Center.

• Certificação médica em Hematologia e Oncologia Médica
• Especialização (Fellowship) no Westchester Medical Center, em Nova Iorque
• Autor de mais de 30 artigos científicos e de um capítulo de manual
• Vasta experiência em distúrbios complexos da medula óssea

Mais de 300 transplantes de medula óssea e sangue do cordão umbilical – A Dra. El Hasid lidera a onco-hematologia pediátrica no Hospital Infantil Dana Dwek.

• Chefe do Departamento de Onco-hematologia e Oncologia Pediátrica
• Membro da Associação Americana de Hematologia
• Publicar 50 artigos de pesquisa na área
• Formação no Hospital City of Hope em Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Mais de 900 transplantes de medula óssea realizados – O Dr. Michael Shapira é um hematologista líder no Sourasky Medical Center.

• Especializar-se em transplante de medula óssea no Hadassah Medical Center
• Ser reconhecido pelo avanço da medicina de transplantes
• Falar inglês e hebraico fluentemente
• Graduar-se na faculdade de medicina da Universidade Hebraica

Chefe do Instituto de Hematologia e Transplante de Medula Óssea do Sourasky Medical Center – O Dr. Aviv traz liderança e profunda experiência em anemia aplástica.

• 31 anos de especialização em hematologia e oncologia
• Certificado pelo conselho com participação em múltiplas sociedades profissionais
• Focar em síndromes mielodisplásicas e transplantes

Diretor de hematologia-oncologia pediátrica no Sourasky Medical Center – Dr. Levin é especialista em distúrbios sanguíneos e câncer ósseo infantil.

• Coordenar o tratamento de sarcoma com o departamento de oncologia-ortopedia
• Especialista em hematologia para recém-nascidos prematuros
• Formado no Instituto Ortopédico Rizzoli, na Itália
• Membro da ISPHO – Associação de hemato-oncologia pediátrica de Israel

O Dr. Kirshner está envolvido em pesquisas de ponta e ensaios clínicos para anemia aplásica, incluindo ensaios de fase III no Sourasky Medical Center.

• Especialização (Fellowship) em hematologia no Montefiore Medical Center
• Especialização em distúrbios sanguíneos raros, como anemia aplásica
• Mais de 30 anos de experiência em hematologia e oncologia
• Foco de pesquisa em protocolos de tratamento inovadores
• Membro (Fellow) da American Society of Hematology

O Dr. Herishanu Yair recebeu vários prémios pelas suas contribuições para a hematologia, incluindo o Young Investigator Research Prize e o Klitzberg Oncology Award.

• Especializar-se em leucemia linfocítica crónica e anemia aplástica
• Membro das Associações de Hematologia de Israel e Americana
• Publicar extensas investigações no campo da hematologia
• Formar-se em instituições médicas de topo em Israel

Realização de mais de 3.500 transplantes de medula óssea – reconhecido pela Forbes como um dos melhores médicos em 2018.

• 20 anos de experiência em hematologia pediátrica
• Especializado no tratamento de crianças com doenças sanguíneas raras
• Conhecido entre os pacientes como «aquele que transplanta vida»
• Trabalha no Hadassah Medical Center

Dra. Irina Zaidman especializa-se em transplante de medula óssea pediátrica – um tratamento crítico para a anemia aplástica – no Hadassah Medical Center.

• Especialização em transplante de medula óssea pediátrico no Hospital for Sick Children em Toronto
• Membro da diretoria da Sociedade Israelense de Hemato-Oncologia Pediátrica
• Membro das sociedades europeia e americana de transplante de medula óssea
• Pesquisas publicadas sobre transplante de medula óssea pediátrico

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

O Dr. Spielberg é um onco-hematologista dedicado no Assuta Medical Center, especializado em distúrbios sanguíneos, como a anemia aplásica.

• Focar no diagnóstico e no planeamento abrangente do tratamento
• Ser especialista na gestão de síndromes de falência da medula óssea
• Trabalhar no maior hospital privado de Israel, o Assuta Medical Center
• Prestar cuidados personalizados para condições hematológicas complexas

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.